Navigation Links
EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
Date:8/20/2007

LYON, France, Aug. 17 /PRNewswire-FirstCall/ -- EDAP TMS S.A. (Nasdaq: EDAP), the global leader in High Intensity Focused Ultrasound (HIFU) treatment of prostate cancer, is currently conducting clinical investigations in France under an approved clinical trial combining the company's Ablatherm-HIFU device with chemotherapy using docetaxel.

The study is a primary treatment therapy program for men suffering from clinically localized but aggressive high risk prostate cancer typically classified as stage T2c. The study began in late 2006 and will enroll a total of 30 men, of which more than 10 have already been treated.

"Combination therapy is well documented as a treatment protocol for men suffering more aggressive prostate cancers," said Dr. Albert Gelet, Edouard Herriot Hospital, Lyon. "Ablatherm-HIFU is a proven effective treatment for localized prostate cancer already with strong clinical support. This study aims to evaluate its use under an additional dedicated protocol for men in the T2c cancer stage where the tumors are known to be more aggressive, creating a higher risk of relapse if the patient is treated with only a localized therapy. It was demonstrated in pre-clinical studies that HIFU improves chemotherapy drug efficacy in the area around burned tissues."

Under the approved protocol by French Ethical Committee, patients are administered a dose of docetaxel 30 minutes prior to a standard primary indication HIFU session lasting an average of two hours. The Ablatherm-HIFU ablates the prostate tissue according to conventional procedures and protocols. All treatments are administered at Edouard Herriot Hospital in Lyon, France.

"EDAP has a strong scientific and clinical base underlying the Ablatherm-HIFU, with constant work to enhance and extend the capabilities of the device," said Pr John Rewcastle, Medical Director for EDAP. "With already well documented specialized protocols for primary therapy, HIFU retreatment and salvage th
'/>"/>

SOURCE EDAP TMS S.A.

Copyright©2007 PR Newswire.

Page: 1 2 3

Related medicine technology :

1. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
2. Sygnis Pharma AG announces date for presentation of clinical results
3. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
4. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
5. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
6. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
7. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
8. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
9. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
10. Protox Announces Positive Clinical Data from Prostate Cancer Study
11. Inspire Announces Webcast of Presentation at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... Wash. , May 22, 2015  BioLife Solutions, Inc. ... of proprietary clinical grade hypothermic storage and ... for cells and tissues ("BioLife" or the "Company"), announced ... Marcum MicroCap Conference. The Company is scheduled ... Wednesday, May 27, 2015 at the Grand Hyatt Hotel in ...
(Date:5/22/2015)... May 22, 2015 The leading companies ... billion global cardiac rhythm management device market dominate ... that Medtronic, St. Jude Medical, Boston Scientific and ... this market segment. The healthcare market research publisher,s ... uses 2015 as a base year, providing forecasts ...
(Date:5/22/2015)... 22, 2015  The U.S. Food and Drug ... the first biosimilar product approved in ... growth in the contract manufacturing organization (CMO) industry, ... is geared to the production of small-molecular drugs ... products. The healthcare market research publisher,s report, ...
Breaking Medicine Technology:BioLife Solutions To Present At The 2015 Marcum MicroCap Conference In New York City 2Kalorama: Top Companies Dominate Cardiac Defibrillator Market 2Kalorama: Top Companies Dominate Cardiac Defibrillator Market 3Kalorama: Top Companies Dominate Cardiac Defibrillator Market 4Kalorama: First FDA-Approved Biosimilar Brings Hope for CMO Growth 2Kalorama: First FDA-Approved Biosimilar Brings Hope for CMO Growth 3Kalorama: First FDA-Approved Biosimilar Brings Hope for CMO Growth 4
... Odyssey Thera, Inc. announced today that the United ... No. 7,855,167.  The invention describes technologies and high-throughput ... based on protein-fragment complementation assays (PCA).  The ... protects assays utilizing fragments of inherently fluorescent proteins, ...
... N.J., Jan. 5, 2011 Amicus Therapeutics (Nasdaq: ... John F. Crowley will be presenting a business update and ... at the upcoming 29th Annual J.P. Morgan Healthcare Conference.  Mr. ... at 3:00 p.m. PST. Individuals can listen to ...
Cached Medicine Technology:
(Date:5/25/2015)... Henderson, NV (PRWEB) May 25, 2015 ... this year, the radical science-based human wellness company ... one-day workshop event from their world-class series titled, “Consciousness ... be held on June 13, 2015 at the routinely ... pm EST. The event will be made available to ...
(Date:5/25/2015)... Burke Rehabilitation Hospital will welcome Samuel White, ... City, to speak at Burke on Wednesday, June 3. The ... Lecture series, will take place at 4:30 p.m. on Burke’s ... of Stanford White of McKim, Mead and White, the famed ... years ago. , “We are thrilled to welcome Samuel White ...
(Date:5/24/2015)... 25, 2015 Pacific Prime has announced that they ... looking at the cost of individual international health insurance. Titled: ... looks at the cost of health insurance in six top expat ... Hong Kong , Singapore , ... UAE , the UK , Article 2 ...
(Date:5/24/2015)... Clarkston, Metamora, Michigan (PRWEB) May 24, 2015 ... patients for concerns about hair loss. Although it is ... clear that there are environmental factors such as metabolism, ... can contribute. Since they offer a comprehensive approach to ... peri and post-menopausal woman, they can help patients find ...
(Date:5/24/2015)... Birmingham, Lake Orion, Clarkston, Metamora, Michigan (PRWEB) May 24, ... urodynamic tests, which will allow them to take pressure ... information about bladder function. The doctor usually orders it ... (SUI) or overactive bladder (OAB). , Women’s ... women that have problems with unwanted urinary leakage or ...
Breaking Medicine News(10 mins):Health News:Hundreds of People Are Thrilled to Hear that Trivedi Master Wellness™ Promises to Hold Another Workshop in June 2015 2Health News:Hundreds of People Are Thrilled to Hear that Trivedi Master Wellness™ Promises to Hold Another Workshop in June 2015 3Health News:Burke Rehabilitation Hospital Welcomes Architect Samuel White, Descendant of McKim, Mead and White, for Legacy Lobby Lecture 2Health News:Burke Rehabilitation Hospital Welcomes Architect Samuel White, Descendant of McKim, Mead and White, for Legacy Lobby Lecture 3Health News:Pacific Prime Releases 2nd Article of Cost of Health Insurance Report 2Health News:Women's Excellence Now Treats Menopausal Hair Loss 2
... June 15 (HealthDay News) -- Most working fathers say they ... a lot of them admit that they aren,t actually doing ... many dads are conflicted about finding a work-family balance, according ... Family. The survey of nearly 1,000 American fathers with ...
... study by the University of California, San Francisco,s Cardiac Electrophysiology ... causes of sudden cardiac death (SCD), why it is more ... often inaccurately cited as a cause of death. Working ... City and County of San Francisco, researchers will fully investigate ...
... -- Weight loss surgery patients who are discharged from the ... risk of complications and death, a new study has found. ... patients, researchers found that those released from the hospital the ... serious complications (1.9 percent versus 0.16 percent) and 13 times ...
... IOF Regionals 1st Middle-East & Africa Osteoporosis Meeting, ... has published its scientific programme at , http://www.iofbonehealth.org/dubai-2011/programme.html ... is offering awards of 1000 USD each for the ... of age. The abstract deadline is June 17, 2011; ...
... On June 21-23, 2011, the New York Academy ... neuropsychologists, cellular and molecular biologists and patient advocates ... improving diagnosis, treatment and management of the cognitive ... conference titled "Cognitive Dysfunction in Multiple Sclerosis: New ...
... , New York, NY, June 15, 2011A new Commonwealth ... are owned by publicly traded for-profit companies whose primary ... average of 14 percent of premiums on administrative costs, ... by non-publicly traded plans owned by groups of health ...
Cached Medicine News:Health News:Sudden cardiac death subject of sweeping UCSF study in San Francisco 2Health News:Sudden cardiac death subject of sweeping UCSF study in San Francisco 3Health News:Rushed Discharge After Weight-Loss Surgery May Raise Risks 2Health News:Program announced for 1st Middle-East & Africa Osteoporosis Meeting 2Health News:The New York Academy of Sciences to host a symposium on cognitive dysfunction in multiple sclerosis 2Health News:Medicaid managed care plans owned by public companies have higher administrative costs 2Health News:Medicaid managed care plans owned by public companies have higher administrative costs 3
The 9114-3.5 transducer is a versatile general imaging transducer. With multifrequencies, this transducer provides superb image quality and meets a multitude of imaging needs....
The versatility of multiple imaging frequencies and a smaller transducer face make this transducer is perfect for intercostal imaging....
... XL3000 by PerkinElmer,is a complete ... in,Cermax Xenon technology.,Cermax Xenon is ... integration into endoscopy,equipment and other ... color illumination.,It provides many advantages ...
... 350 Chemistry System offers easy operation, maintenance, and ... STAT, or back-up to the powerful VITROS 5,1 ... the job done right the first time. Its ... are efficient, dependable, and easy-to-use. The VITROS 350 ...
Medicine Products: